Micro-Sample
Mini Sample Human LEP ( Leptin ) ELISA Kit (E-MSEL-H0003)
Add to cart
For research use only.
Product Summary
| Sensitivity | 23.44 pg/mL |
| Detection Range | 39.06-2500 pg/mL |
| Sample Volume | 25 μL |
| Manual Operation Time | 1 h |
| Total Assay Time | 3 h 30 min |
| Reactivity | Human |
| Specificity | This kit recognizes LEP in samples.No significant cross-reactivity or interference between LEP and analogues was observed. |
| Recovery | 80%-120% |
| Sample Type | Serum, plasma and other biological fluids |
| Detection Method | Colorimetric method, ELISA, Sandwich |
| Assay Type | Sandwich-ELISA |
| Size | 96T / 48T / 24T / 96T*5 / 96T*10 |
| Storage | 2-8℃ |
| Expiration Date | 12 months |
Performance
| Typical data |
The following data was generated by the Quality Control Department, under controlled laboratory conditions (ambient temperature: 18-25 °C, relative humidity: 35-75%) using standardized procedures (TMB reaction at 37 °C in the dark for 15 minutes, followed by termination and OD measurement). These values are provided for reference only.
Actual results may vary due to differences in laboratory conditions, operator technique, and equipment. Users are required to generate a standard curve using their own experimental data.
|
|||||||||||||||||||||||||||||||||||||||||||||
| Precision |
Intra-assay Precision (Within-run Precision): Three samples representing low, mid, and high concentrations of Human LEP were tested 20 times on a single plate.
Inter-assay Precision (Between-run Precision): Three samples representing low, mid, and high concentrations of Human LEP were tested on three separate plates, with 20 replicates per plate, to assess variability among assays.
|
|||||||||||||||||||||||||||||||||||||||||||||
| Recovery |
The recovery of Human LEP was evaluated by spiking samples at low, mid, and high concentrations across the assay range in various sample matrices.
The assay performance was assessed by comparing the measured concentrations to the expected spiked amounts to determine the percent recovery.
|
|||||||||||||||||||||||||||||||||||||||||||||
| Linearity |
Linearity of the assay was evaluated by spiking samples with high concentrations of Human LEP and performing serial dilutions using Standard & Sample Diluent to produce concentrations spanning the assay's dynamic range.
The measured values were then compared to the expected concentrations to assess the linearity of response.
|
|||||||||||||||||||||||||||||||||||||||||||||
| Stability |
Each kit batch is subjected to accelerated stability testing and real-time stability monitoring. Sample performance is evaluated after storage at 37 °C for 10 days to assess the impact of elevated temperature on assay reliability and reagent integrity.
|
|||||||||||||||||||||||||||||||||||||||||||||
Test Principle
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to LEP . Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for LEP and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain LEP , biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of LEP . You can calculate the concentration of LEP in the samples by comparing the OD of the samples to the standard curve.
Background
Leptin is a 167-amino-acid, 16 kDa non-glycosylated polypeptide encoded by the LEP (ob) gene and secreted mainly by white adipose tissue, although the stomach, placenta, mammary gland, skeletal muscle and bone marrow also produce it. Circulating concentrations are proportional to total body fat mass, are higher in females than in males at any given adiposity, and are regulated by insulin, glucocorticoids, sex steroids, inflammatory cytokines and food intake; secretion is pulsatile with a diurnal rhythm. Leptin circulates partly bound to a soluble form of its receptor and reaches the hypothalamus through a saturable transport system across the blood-brain barrier.
Leptin signals through the leptin receptor (LEPR), a class I cytokine receptor with several alternatively spliced isoforms; the long isoform mediates signalling in the arcuate nucleus and other hypothalamic nuclei through JAK2-STAT3, PI3K and SHP2-MAPK pathways. In the arcuate nucleus, leptin suppresses the orexigenic agouti-related peptide and neuropeptide Y neurons and activates anorexigenic pro-opiomelanocortin and cocaine- and amphetamine-regulated transcript neurons, reducing food intake and increasing energy expenditure and sympathetic tone. Leptin is also permissive for the hypothalamic-pituitary-gonadal, thyroid and growth hormone axes, and it modulates immune cell function, haematopoiesis, bone metabolism and glucose homeostasis. In states of energy deficit, the fall in leptin is a key signal triggering adaptive responses such as increased appetite, reduced energy expenditure, suppressed reproduction and altered immune function.
In human disease, congenital leptin deficiency caused by loss-of-function LEP mutations produces severe early-onset obesity, hyperphagia, insulin resistance and hypogonadotropic hypogonadism that respond dramatically to recombinant leptin (metreleptin), and the same treatment is effective in generalized lipodystrophy, in which leptin is extremely low and metabolic complications are severe. Relative leptin resistance, reflecting impaired transport or signalling rather than deficiency, is a hallmark of common obesity and contributes to its metabolic and cardiovascular complications. Low leptin concentrations accompany hypothalamic amenorrhoea, eating disorders and exercise-induced energy deficiency, and leptin has been studied as a marker linking adipose tissue to inflammation, autoimmunity and bone density. Measurement of leptin is therefore used in energy-balance and obesity research, in the diagnosis and follow-up of leptin deficiency and lipodystrophy, and in studies of reproductive and neuroendocrine function.
| Gene Alias | LEP |
| Gene ID | 3952 |
| Uniport ID | P41159 |
| Protein Alias | LEP |
| Research Area | Cancer , Cardiovascular , Metabolism , Neuroscience , SignalTransduction , Stemcells |
-
IF:{{item.impact}}
Journal:{{item.journal}} ({{item.year}})
DOI:{{item.doi}}Reactivity:{{item.species}}
Sample Type:{{item.sample_type}}
-
Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}
No files available. Please enter the correct identification code in the search area to query the relevant documents.
| Title | Status | Valid until | Action | |
|---|---|---|---|---|
| {{v.文件名}} | {{v.status_str}} | {{v.timestamp_str}} | Download | / |
*Note:Please download the relevant files within the validity period. After expiration, file preview and download will not be available on the page.
Resources
Contact with Us
Toll-free: 1-888-852-8623
Tel: 1-832-243-6086
Add:
14780 Memorial Drive, Suite 105, Houston, Texas, 77079, USA

